FENC
Price
$8.80
Change
+$0.26 (+3.04%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
240.63M
35 days until earnings call
GNFT
Price
$3.80
Change
-$0.09 (-2.31%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
196.8M
81 days until earnings call
Interact to see
Advertisement

FENC vs GNFT

Header iconFENC vs GNFT Comparison
Open Charts FENC vs GNFTBanner chart's image
Fennec Pharmaceuticals
Price$8.80
Change+$0.26 (+3.04%)
Volume$4.19K
Capitalization240.63M
Genfit SA
Price$3.80
Change-$0.09 (-2.31%)
VolumeN/A
Capitalization196.8M
FENC vs GNFT Comparison Chart in %
Loading...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FENC vs. GNFT commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FENC is a Buy and GNFT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (FENC: $8.80 vs. GNFT: $3.87)
Brand notoriety: FENC and GNFT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FENC: 88% vs. GNFT: 5%
Market capitalization -- FENC: $240.63M vs. GNFT: $196.8M
FENC [@Biotechnology] is valued at $240.63M. GNFT’s [@Biotechnology] market capitalization is $196.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FENC’s FA Score shows that 0 FA rating(s) are green whileGNFT’s FA Score has 1 green FA rating(s).

  • FENC’s FA Score: 0 green, 5 red.
  • GNFT’s FA Score: 1 green, 4 red.
According to our system of comparison, GNFT is a better buy in the long-term than FENC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FENC’s TA Score shows that 3 TA indicator(s) are bullish while GNFT’s TA Score has 5 bullish TA indicator(s).

  • FENC’s TA Score: 3 bullish, 4 bearish.
  • GNFT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, GNFT is a better buy in the short-term than FENC.

Price Growth

FENC (@Biotechnology) experienced а +6.28% price change this week, while GNFT (@Biotechnology) price change was +0.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

FENC is expected to report earnings on Aug 07, 2025.

GNFT is expected to report earnings on Sep 22, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FENC($241M) has a higher market cap than GNFT($197M). GNFT has higher P/E ratio than FENC: GNFT (109.28) vs FENC (64.14). FENC YTD gains are higher at: 39.241 vs. GNFT (4.172).
FENCGNFTFENC / GNFT
Capitalization241M197M122%
EBITDA-10.34MN/A-
Gain YTD39.2414.172941%
P/E Ratio64.14109.2859%
Revenue30.9MN/A-
Total Cash22.7MN/A-
Total Debt19.4MN/A-
FUNDAMENTALS RATINGS
FENC vs GNFT: Fundamental Ratings
FENC
GNFT
OUTLOOK RATING
1..100
5752
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
96100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
4162
P/E GROWTH RATING
1..100
982
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GNFT's Valuation (83) in the Biotechnology industry is in the same range as FENC (90). This means that GNFT’s stock grew similarly to FENC’s over the last 12 months.

FENC's Profit vs Risk Rating (96) in the Biotechnology industry is in the same range as GNFT (100). This means that FENC’s stock grew similarly to GNFT’s over the last 12 months.

GNFT's SMR Rating (96) in the Biotechnology industry is in the same range as FENC (100). This means that GNFT’s stock grew similarly to FENC’s over the last 12 months.

FENC's Price Growth Rating (41) in the Biotechnology industry is in the same range as GNFT (62). This means that FENC’s stock grew similarly to GNFT’s over the last 12 months.

GNFT's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for FENC (98). This means that GNFT’s stock grew significantly faster than FENC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FENCGNFT
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADMLF3.700.06
+1.65%
Adriatic Metals PLC
MRZLF0.29N/A
N/A
Mirasol Resources Ltd.
TMRAY15.55N/A
N/A
Tomra Systems A/S/A
GRYCF0.02N/A
N/A
Graycliff Exploration Limited
ELEZY15.68-0.18
-1.13%
Endesa S.A.

FENC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FENC has been loosely correlated with DNLI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FENC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FENC
1D Price
Change %
FENC100%
+3.04%
DNLI - FENC
46%
Loosely correlated
-1.41%
CLDX - FENC
45%
Loosely correlated
-0.50%
BEAM - FENC
45%
Loosely correlated
+0.65%
IDYA - FENC
44%
Loosely correlated
+0.82%
ATXS - FENC
42%
Loosely correlated
+1.40%
More

GNFT and

Correlation & Price change

A.I.dvisor tells us that GNFT and CVALF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNFT and CVALF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNFT
1D Price
Change %
GNFT100%
-0.51%
CVALF - GNFT
25%
Poorly correlated
+4.97%
ORMP - GNFT
25%
Poorly correlated
+0.93%
GLTO - GNFT
25%
Poorly correlated
N/A
CAPR - GNFT
24%
Poorly correlated
+2.30%
FENC - GNFT
24%
Poorly correlated
+3.04%
More